×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [allogeneic sct]
Introduction Statistics are increasingly prevalent in medical practice, and for those doing research, statistical issues are fundamental. It is extremely
213 views
1 TMR Journal Club - March 5, 2008 Maggie Constantine, MD, FRCPC (Hematology) Resident, Transfusion Medicine (UBC) Transfusion 2007;47:1972-1983
213 views
Innovation in Cell Therapy with Miltenyi Biotech 25 Years
261 views
Wei Ai, M.D., Ph.D. June 2012. I. Lymphoma: bendamustine II. CLL/SLL: Btk inhibitor III. Pre-B ALL: Bite biphasic antibody IV. Multiple Myeloma: Carfilzomib
215 views
Www.ebmt.org #EBMT2015 IEWP – EBMT 2015 Business Meeting Monday 08.00 23 rd March 2015
216 views
How do transplants fit in the current therapeutic schema?
79 views
HSCT in a patient with hyper IgM sy n drome - our recent experience -
44 views
TMR Journal Club - March 5, 2008 Maggie Constantine, MD, FRCPC (Hematology)
22 views
DLBCL with less than PR to second line therapy… Correcting a Misconception…. Koen van Besien, MD Weill Cornell Medical College, NY
214 views
Kanti R. Rai, MD NSLIJ-Hofstra School of Medicine Long Island Jewish Medical Center
83 views